SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism

Carlos G. Santos-Gallego; Manuel Mayr; Juan Badimon

doi:10.1161/CIRCULATIONAHA.122.060805

SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism

Carlos G. Santos-Gallego
, Manuel Mayr
, Juan Badimon

Research output: Contribution to journal › Review article › peer-review

54 Scopus citations

Original language	English
Pages (from-to)	819-821
Number of pages	3
Journal	Circulation
Volume	146
Issue number	11
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.122.060805
State	Published - 13 Sep 2022

Keywords

Editorials
clinical trial
heart failure
metabolism
metabolomics
pharmacology

Access to Document

10.1161/CIRCULATIONAHA.122.060805

Cite this

@article{a44f2b53bff04544b5393c77c6104256,

title = "SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism",

keywords = "Editorials, clinical trial, heart failure, metabolism, metabolomics, pharmacology",

author = "Santos-Gallego, \{Carlos G.\} and Manuel Mayr and Juan Badimon",

year = "2022",

month = sep,

day = "13",

doi = "10.1161/CIRCULATIONAHA.122.060805",

language = "English",

volume = "146",

pages = "819--821",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

TY - JOUR

T1 - SGLT2 Inhibitors in Heart Failure

T2 - Targeted Metabolomics and Energetic Metabolism

AU - Santos-Gallego, Carlos G.

AU - Mayr, Manuel

AU - Badimon, Juan

PY - 2022/9/13

Y1 - 2022/9/13

KW - Editorials

KW - clinical trial

KW - heart failure

KW - metabolism

KW - metabolomics

KW - pharmacology

UR - https://www.scopus.com/pages/publications/85137735903

U2 - 10.1161/CIRCULATIONAHA.122.060805

DO - 10.1161/CIRCULATIONAHA.122.060805

M3 - Review article

C2 - 36095062

AN - SCOPUS:85137735903

SN - 0009-7322

VL - 146

SP - 819

EP - 821

JO - Circulation

JF - Circulation

IS - 11

ER -